Abstract: A method for wire bristle tuft attachment. The method includes clamping a brush head of a grill brush using a fixture, arranging a plurality of bristles to form a bristle grouping using a terminal, inserting the plurality of bristles in a recess in the brush head, and forming an irregular bend in the terminal by pressing the terminal into the recess by a press machine.

Abstract: The present disclosure relates to use of Rivastigmine in the preparation of an anti-radiation medicament, and belongs to the field of medical technology. The present disclosure provides use of Rivastigmine in the preparation of an anti-radiation medicament. Researches show that Rivastigmine significantly promoted the proliferation of Lgr5+ stem cells receiving 10 Gy radiation (after being irradiated with 10 Gy radiation for 10 d, Lgr5+ stem cells cultured in a Rivastigmine-containing culture solution had an increment 14.2 times of that of the Lgr5+ stem cells cultured in a Rivastigmine-free culture solution). Rivastigmine also significantly reduced the mortality of mice after being irradiated with 10 Gy radiation (after receiving 10 Gy whole body irradiation, all the mice not intraperitoneally injected Rivastigmine died within 10 d; and for the mice intraperitoneally injected Rivastigmine, the survival rate of the mice was still greater than 40% 30 d later), and thus might have good radiation-proof effect.

Abstract: A package structure includes a second substrate. A second component is connected to the second substrate, and at least a part of the second component is connected to the second connecting rod through the second heat dissipation block, so that heat of the at least a part of the second component can be further transferred to the second connecting rod through the second heat dissipation block, and then transferred, through the second connecting rod, to the second substrate or another structure connected to the second connecting rod. In this way, the heat of the second component is transferred out, and heat conduction paths of the second component are increased.

Abstract: A vapor chamber and a mobile terminal are provided. The vapor chamber comprises a first cover plate, a second cover plate, a housing including the first cover plate and the second cover plate, wherein the first cover plate and the second cover plate are connected to form a sealed cavity, a cooling medium, a capillary structure disposed in the sealed cavity, and a supporting structure extending from an inner surface of the housing to an internal space of the housing. A material of the first cover plate and the second cover plate is a high-strength composite material, wherein the high-strength composite material comprises a first material layer and a second material layer. The vapor chamber has light weight, small thickness and structural strength.

Abstract: The present disclosure relates to use of Rivastigmine in the preparation of an anti-radiation medicament, and belongs to the field of medical technology. The present disclosure provides use of Rivastigmine in the preparation of an anti-radiation medicament. Researches show that Rivastigmine significantly promoted the proliferation of Lgr5+ stem cells receiving 10Gy radiation (after being irradiated with 10Gy radiation for 10 d, Lgr5+ stem cells cultured in a Rivastigmine-containing culture solution had an increment 14.2 times of that of the Lgr5+ stem cells cultured in a Rivastigmine-free culture solution). Rivastigmine also significantly reduced the mortality of mice after being irradiated with 10Gy radiation (after receiving 10Gy whole body irradiation, all the mice not intraperitoneally injected Rivastigmine died within 10 d; and for the mice intraperitoneally injected Rivastigmine, the survival rate of the mice was still greater than 40% 30 d later), and thus might have good radiation-proof effect.

Abstract: This invention discloses a novel compound with the structure of formula I, or pharmaceutically acceptable salts or solvates thereof. In addition, the invention further discloses a method for preparing the compound, a pharmaceutical composition containing the compound, and use thereof in the preparation of a hypoglycemic medicament.

Abstract: A delta-sigma modulation apparatus and a dynamic element-matching circuit thereof are disclosed. The dynamic element-matching circuit includes a data aligner, a logic operation circuit, and a delayer. The data aligner receives an input matching data and a pointer signal and shifts the input matching data according to the pointer signal to generate an output matching data. The logic operation circuit receives the output matching data and performs a logic operation on the output matching data to generate a preceding pointer signal. The delayer receives the preceding pointer signal and delays the preceding pointer signal according to a sample clock pulse to generate the pointer signal.

Abstract: A display supporting device comprises a supporting sleeve, a pivotable head, a first fastener, a second fastener, and a third fastener. The supporting sleeve has a circular hollow cross-section and a penetrating hole on the side wall thereof The pivotable head has a head portion and a neck portion. The neck portion has two stopping sections and is adapted to rotatably couple the supporting sleeve to enable lateral angle adjustment. The first fastener is arranged in the pivotable head for coupling a display unit. The second fastener has an attaching hole correspondingly aligns the penetrating hole, enabling horizontal rotation of the pivotable head about the second fastener. The third fastener passes through the penetrating hole of the supporting sleeve and the attaching hole of the second fastener. The horizontal rotation of the pivotable head is restricted through the contact between the stopping sections thereof and the third fastener.

Abstract: This invention discloses a novel compound with the structure of formula I, or pharmaceutically acceptable salts or solvates thereof. In addition, the invention further discloses a method for preparing the compound, a pharmaceutical composition containing the compound, and use thereof in the preparation of a hypoglycemic medicament.

Abstract: An apparatus and a method for controlling a screen are disclosed herein, the apparatus includes an object detection module and an adjusting device. The object detection module can detect a position of at least one object. A position analyzer recognizes the position of the object and the adjusting device can set the screen to a predetermined position according to the result recognized by the position analyzer.

Abstract: A brightness adjustment system includes a camera, a computer, and a liquid crystal display. The liquid crystal display includes a signal processor, a backlight control circuit and a backlight unit. The camera captures environmental images and sends the environmental image to the computer. The computer analyzes the environmental image to obtain a environmental brightness and sends a control signal to the signal processor according to the environmental brightness. The signal processor receives the control signal and sends an adjusting signal to the backlight unit according to the control signal. The backlight control circuit adjusts a brightness of the backlight unit according to the adjusting signal. A method of automatically adjusting brightness of a liquid crystal display is also provided.